Case studies

Our work is reshaping the medicines discovery industry. Here are some examples of the innovative case studies we have been involved in.
































Filters

5 case studies found

Using a data-driven approach to identify drug candidates for Multiple Sclerosis

A collaboration with the MS Society


Find out more
Delivering the next generation drug discovery pipeline; New approaches to target identification and target validation

A workshop co-hosted by the Psychiatry Consortium and the Psychiatric Genomics Consortium


Find out more
Supporting the UK’s fight against Coronavirus

MDC’s COVID-19 response


Find out more
Boehringer Ingelheim and MDC event focused on hearing disorders

MDC and Boehringer Ingelheim collaborate to organise a consultative ‘round table’ meeting providing an opportunity for hearing research innovators to access industry-leading insight and expertise on the development of their hearing therapeutic programme.


Find out more
NC3Rs technology to tools competition

Accelerating translation of more predictive research models for drug discovery


Find out more





Partner with us and make sure your next move counts

See how we can help support you with your next drug discovery project.

Speak to us



We are ISO 45001 certified 

The world’s first international standard for occupational health and safety. The accreditation has been certified by Interface NRM, a UKAS and ASI–accredited certification body.











Medicines Discovery Catapult